Patent Applications published on Nov 2, 2023 - page 4

#901
US20230346760A1
Human necessities

AGENTS TO PREVENT TISSUE DAMAGE FROM CLOSTRIDIUM DIFFICILE INFECTIONS BY INHIBITION OF THE GUT-DAMAGING BACTERIAL TOXINS TCDA AND TCDB

#902
US20230346761A1
Human necessities

REPURPOSING FDA-APPROVED DRUGS AS A NOVEL CANCER THERAPEUTIC AVENUE THROUGH INHIBITION OF PRMT5

#903
US20230346762A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING MTOR-SIGNALING INHIBITOR AS ACTIVE INGREDIENT

#904
US20230346763A1
Human necessities

METHOD FOR PREPARING SOLID FORMULATION OF PIMAVANSERIN

#905
US20230346764A1
Human necessities

Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR3-Inhibitors

#906
US20230346765A1
Human necessities

METHODS OF TREATING XANTHINE OXIDASE-RELATED DISEASES WITH NIFLUMIC ACID AND DERIVATIVES THEREOF

#907
US20230346766A1
Human necessities

TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION

#908 ✅ Patent 12,083,110 granted on 2024-09-10
US20230346767A1
Human necessities

Nicotine lozenge

#909 ✅ Patent 12,005,058 granted on 2024-06-11
US20230346768A1
Human necessities

Nicotine tablet

#910
US20230346769A1
Human necessities

USE OF SIMPLE ACYCLIC POLYAMINES FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENUS LEISHMANIA

#911
US20230346770A1
Human necessities

COMBINATION OF BEDAQUILINE, ETHAMBUTOL AND A MACROLIDE IN THE TREATMENT OF NONTUBERCULOUS MYCOBACTERIAL DISEASES

#912
US20230346771A1
Human necessities

INHIBITORS OF ENPP1 AND MODULATION OF BONE GROWTH

#913
US20230346772A1
Human necessities

COMBINATION TREATMENTS FOR WALDENSTROM'S MACROGLOBULINEMIA

#914
US20230346773A1
Human necessities

USE OF PCSK9 INHIBITOR IN PREPARATION OF PRODUCT FOR TREATING MULTIPLE DISEASES

#915
US20230346774A1
Human necessities

METHODS OF STIMULATING AN ANTI-TUMOR RESPONSE USING A SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR

#916
US20230346775A1
Human necessities

CANCER TREATMENT WITH TLR AGONIST

#917
US20230346776A1
Human necessities

VETERINARY COMPOSITION FOR DAIRY RUMINANTS FOR TREATMENT OF MILK FEVER

#918
US20230346777A1
Human necessities

USE OF SGC ACTIVATORS FOR THE TREATMENT OF OPHTHALMOLOGIC DISEASES

#919
US20230346779A1
Human necessities

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BTK AND MUTANTS THEREOF

#920 ✅ Patent 11,975,001 granted on 2024-05-07
US20230346780A1
Human necessities

Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one

#921 ✅ Patent 12,263,165 granted on 2025-04-01
US20230346781A1
Human necessities

Small molecule inhibitors of cancer stem cells and mesenchymal cancer types

#922
US20230346782A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING GALACTOSEMIA

#923
US20230346783A1
Human necessities

THERAPEUTIC STRATEGIES TO MANAGE FACIAL CONTRACTURES POST INJURY

#924
US20230346784A1
Human necessities

METHOD FOR TREATING COMPLEMENT MEDIATED DISORDERS CAUSED BY BETACORONAVIRUSES

#925
US20230346785A1
Human necessities

4-PYRROLIDIN-1-Yl-5-P-TOLYL-THIENO[2,3-D] PYRIMIDINE FOR USE IN THE TREATMENT OF AGING-ASSOCIATED AND PREMATURE AGING DISEASES THROUGH RESTORED CHROMOSOMAL STABILITY AND INHIBITION OF CELLULAR SENESCENCE

#926 ✅ Patent 12,310,968 granted on 2025-05-27
US20230346786A1
Human necessities

Chiral diaryl macrocycles and uses thereof

#927 ✅ Patent 12,194,044 granted on 2025-01-14
US20230346787A1
Human necessities

Organic compounds

#928
US20230346788A1
Human necessities

METHODS FOR TREATING VIRAL DISORDERS

#929
US20230346789A1
Human necessities

METHODS OF TREATING ENHANCING BRAIN TUMORS USING COMBINATION THERAPY

#930
US20230346790A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCERS ASSOCIATED WITH KRAS MUTATION

#931
US20230346791A1
Human necessities

ATR INHIBITORS FOR THE TREATMENT OF CANCER

#932
US20230346792A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING LUNG INFLAMMATION

#933
US20230346793A1
Human necessities

Compositions and Methods for Treating SARS-CoV-2

#934 ✅ Patent 12,310,973 granted on 2025-05-27
US20230346794A1
Human necessities

Administration and dosage of diaminophenothiazines

#935
US20230346795A1
Human necessities

METHODS FOR ACUTE AND LONG-TERM TREATMENT OF ALCOHOL DEPENDENCE USING IBOGAINE AND DERIVATIVES THEREOF

#936 ✅ Patent 12,201,637 granted on 2025-01-21
US20230346796A1
Human necessities

Dosing regimen for sedation with CNS 7056 (Remimazolam)

#937
US20230346797A1
Human necessities

INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS

#938 ✅ Patent 11,975,009 granted on 2024-05-07
US20230346798A1
Human necessities

Use of zinc porphyrin as an antimicrobial

#939
US20230346799A1
Human necessities

Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension

#940
US20230346800A1
Human necessities

REDUCTION OF THE INCIDENCE OR RECURRENCE OF BREAST CANCER IN POSTMENOPAUSAL WOMEN TREATED WITH INTRAVAGINAL SEX STEROID PRECURSOR

#941
US20230346801A1
Human necessities

USE OF AGENTS FOR TREATMENT OF RESPIRATORY CONDITIONS

#942
US20230346802A1
Human necessities

UNIT DOSE PHARMACEUTICAL OF A DRY POWDER OF ONE OR MORE GLUCOCORTICOID OR MINERALOCORTICOID FLUDROCORTISONE ACETATE AND/OR TRIAMCINOLONE ACETONIDE COMPRISED IN A SYRINGE

#943
US20230346803A1
Human necessities

COMPOSITIONS OF BERBERINE URSODEOXYCHOLATE AND METHODS THEREOF FOR TREATING PRIMARY SCLEROSING CHOLANGITIS

#944
US20230346804A1
Human necessities

METHODS AND COMPOSITIONS FOR REDUCING PARATHYROID LEVELS

#945
US20230346805A1
Human necessities

COMPOSITIONS AND METHODS AND USES THEREOF

#946
US20230346806A1
Human necessities

COMBINATION CANNABINOID-PHENYLETHANOID FORMULATION FOR TREATMENT OF INFLAMMATION AND METHODS RELATED THERETO

#947
US20230346807A1
Human necessities

METHODS FOR PRODUCING CANNABINOID-CONTAINING CRYSTALS USING SUPERCRITICAL FLUID

#948
US20230346808A1
Human necessities

CANNABINOID FORMULATIONS AND METHODS OF USE

#949
US20230346809A1
Human necessities

USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES

#950
US20230346810A1
Human necessities

ENDOGENOUS STABILIZATION OF CANNABINOIDS

#951
US20230346811A1
Human necessities

Novel Formulations of Psilocybin And Psilocin Compounds as Serotonin Agonists in Combination With 3,4 Methylenedioxymethamphetamine (MDMA)

#952
US20230346812A1
Human necessities

METHODS FOR TREATING SARS COV-2 INFECTIONS

#953 ✅ Patent 11,850,255 granted on 2023-12-26
US20230346813A1
Human necessities

Pipette tip system

#954
US20230346814A1
Human necessities

METHODS OF MODULATING T-CELL ACTIVATION USING CARBORANES AND CARBORANE ANALOGS

#955
US20230346815A1
Human necessities

LMP7-SELECTIVE INHIBITORS FOR THE TREATMENT OF BLOOD DISORDERS AND SOLID TUMORS

#956
US20230346816A1
Human necessities

COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTION

#957
US20230346817A1
Human necessities

COMPOSITION AND USE OF SGLT-2 INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKERS

#958
US20230346818A1
Human necessities

COMPOSITIONS AND METHODS CONTAINING N-ACETYLCYSTEIN AND NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS

#959
US20230346819A1
Human necessities

5'-MODIFIED CARBOCYCLIC RIBONUCLEOTIDE DERIVATIVES AND METHODS OF USE

#960
US20230346820A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SARS-COV-2

#961
US20230346821A1
Human necessities

RNA AND NUCLEIC ACID CARRIER INCLUDING THE SAME

#962
US20230346823A1
Human necessities

UTILIZATION OF VITAMIN B12 IN INHIBITING RENAL DISORDER

#963
US20230346824A1
Human necessities

MEANS AND METHODS OF PREVENTING AND TREATING INFECTIONS

#964
US20230346825A1
Human necessities

CYCLODEXTRIN DERIVATIVES IN THE TREATMENT OR PREVENTION OF LYSOSOMAL NEURODEGENERATIVE DISEASES

#965
US20230346826A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING AUTOIMMUNE DISORDERS

#966
US20230346827A1
Human necessities

TREATMENT OF CORONAVIRUS INFECTIONS

#967
US20230346828A1
Human necessities

COMPOSITIONS COMPRISING SULFATED POLYSACCHARIDES

#968
US20230346829A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS

#969
US20230346830A1
Human necessities

TREATMENT OF A VIRAL PANDEMIC USING CIGARETTES WITH ADDED NITRATES

#970
US20230346831A1
Human necessities

METHODS FOR TREATING METASTATIC CANCER USING LOW DOSE CARBON MONOXIDE

#971
US20230346832A1
Human necessities

INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY

#972 ✅ Patent 12,144,823 granted on 2024-11-19
US20230346833A1
Human necessities

Porous silicate and/or aluminosilicate matrix/cerium oxide nanoparticle nanocarrier for combination anti-cancer therapeutic and antioxidant delivery

#973 ✅ Patent 12,370,216 granted on 2025-07-29
US20230346834A1
Human necessities

CANCER-KILLING CELLS

#974
US20230346835A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR TARGETING BCMA AND USE THEREOF

#975
US20230346836A1
Human necessities

GENETICALLY ENGINEERED T CELLS WITH DISRUPTED CASITAS B-LINEAGE LYMPHOMA PROTO-ONCOGENE-B (CBLB) AND USES THEREOF

#976
US20230346837A1
Human necessities

PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS

#977
US20230346838A1
Human necessities

Chimeric Antigen Receptor

#978
US20230346839A1
Human necessities

BLOOD PLASMA-CONTAINING COMPOSITIONS

#979 ✅ Patent 12,290,534 granted on 2025-05-06
US20230346840A1
Human necessities

Pain relief composition and method of use

#980
US20230346841A1
Human necessities

COMPOSITIONS, METHODS AND USES FOR IN VITRO AND IN VIVO GENERATION OF FUNCTIONAL THYMIC TISSUE

#981
US20230346842A1
Human necessities

Methods and Compositions For Reducing Joint Inflammation Using Mesenchymal Stem Cells

#982
US20230346843A1
Human necessities

Stem Cells for Treatment of Respiratory Disorders

#983
US20230346844A1
Human necessities

TARGETED DISRUPTION OF T CELL RECEPTOR GENES USING ENGINEERED ZINC FINGER PROTEIN NUCLEASES

#984
US20230346845A1
Human necessities

USES OF MSC IN IMPROVING THROMBOTIC COMPLICATIONS IN COVID-19 PNEUMONIA

#985
US20230346846A1
Human necessities

METHOD OF TREATING GRAFT VERSUS HOT DISEASE

#986
US20230346847A1
Human necessities

JUVENILE PROTECTIVE FACTORS TO ARREST AND REVERSE AGING IN THE ENTERIC NERVOUS SYSTEM

#987
US20230346848A1
Human necessities

FIBROBLAST AND TLR ACTIVATED FIBROBLAST TREATMENT OF VIRAL INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME

#988
US20230346849A1
Human necessities

Appetite Suppressant and Method of Use

#989
US20230346850A1
Human necessities

Therapeutic Bacterial Composition

#990
US20230346851A1
Human necessities

SALMONELLA STRAIN FOR TREATING CANCER AND USE THEREOF

#991
US20230346852A1
Human necessities

APPLICATION OF BACTERIA IN PREPARATION OF SYNERGIST FOR IMMUNE CHECKPOINT INHIBITOR

#992
US20230346853A1
Human necessities

Probiotic Lyophilizate Reactivation Composition for Improving Intestinal Survivability and Adhesion of Probiotics

#993
US20230346854A1
Human necessities

MICROBIALS AND ANTIBIOTICS

#994
US20230346855A1
Human necessities

STABLE BACTERIAL EXTRACTS AS PHARMACEUTICALS

#995
US20230346856A1
Human necessities

Bifidobacterium brevis and its application in preventing or alleviating psoriasis thereof

#996
US20230346857A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING WEISSELLA CIBARIA WIKIM28 AS ACTIVE INGREDIENT

#997
US20230346858A1
Human necessities

FEED AND COMPOSITION COMPRISING LACTIC ACID BACTERIA AND FATTY ACID

#998 ✅ Patent 11,938,158 granted on 2024-03-26
US20230346859A1
Human necessities

Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause

#999 ✅ Patent 12,239,676 granted on 2025-03-04
US20230346860A1
Human necessities

Synbiotic composition for improving immune response and antioxidant capacity during aging and a process for the preparation thereof

#1000
US20230346861A1
Human necessities

PHAGE DELIVERY OF ANTI-INFLAMMATORY PEPTIDES

#1001
US20230346862A1
Human necessities

CANCER ERADICATING - BIO-NANOPARTICLES (CE-BNP)

#1002 ✅ Patent 12,295,979 granted on 2025-05-13
US20230346863A1
Human necessities

Immuno-modulated replication-efficient Vaccinia virus strain

#1003
US20230346864A1
Human necessities

Compositions and Methods for Joint Health

#1004
US20230346865A1
Human necessities

MACA COMPOSITIONS AND METHODS OF USE

#1005
US20230346866A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NON-MALIGNANT RESPIRATORY DISEASE

#1006
US20230346867A1
Human necessities

WELLNESS SPRAY FORMULATIONS

#1007
US20230346868A1
Human necessities

KAVA COMPOSITIONS AND METHODS OF USE

#1008
US20230346869A1
Human necessities

FORMULATION FOR MANAGEMENT OF POST-ORAL SURGICAL RECOVERY AND MAINTENANCE OF ORAL HEALTH

#1009
US20230346870A1
Human necessities

KITS FOR MANUFACTURING INHALABLE FORMULATIONS OF MEDICINAL CANNABIS COMPOUNDS FOR AEROSOL DEVICES, APPARATUSES, AND METHODS FOR MAKING AND USING THE SAME

#1010
US20230346871A1
Human necessities

COMPOSITIONS COMPRISING AQUEOUS OIL PALM FRUIT EXTRACT FOR INCREASING TYROSINE HYDROXYLASE LEVELS AND IMPROVING BRAIN HEALTH

#1011
US20230346872A1
Human necessities

TREATMENT AND PREVENTION OF CORONAVIRUS INFECTION

#1012
US20230346873A1
Human necessities

Enhanced Mediterranean Diet-Based Nutritional Compositions And Methods

#1013
US20230346874A1
Human necessities

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS

#1014 ✅ Patent 12,214,009 granted on 2025-02-04
US20230346875A1
Human necessities

Compositions and methods for improving bruising and rejuvenating skin

#1015
US20230346876A1
Human necessities

IMPROVED WOUND CARE DEVICE

#1016 ✅ Patent 12,133,878 granted on 2024-11-05
US20230346877A1
Human necessities

Pharmaceutical compositions having a selected release duration

#1017
US20230346878A1
Human necessities

Treatment of Abdominal Pain Associated with Diarrhea-Predominant Irritable Bowel Syndrome

#1018
US20230346879A1
Human necessities

COMPOSITIONS AND METHODS FOR COMBINATORIAL DRUG DISCOVERY IN NANOLITER DROPLETS

#1019
US20230346880A1
Human necessities

TOPICAL FORMULATIONS FOR TREATMENT OF HYPERGRANULATION TISSUE

#1020
US20230346881A1
Human necessities

Stable Formulations of Linaclotide

#1021
US20230346883A1
Human necessities

COMPOSITIONS FOR AND METHODS OF TREATMENT WITH MUTANT A1 ADENOSINE RECEPTOR PLASMID cDNAs

#1022
US20230346884A1
Human necessities

Molecular Targets for Modulation of Dissociative and Associative States

#1023
US20230346885A1
Human necessities

Peptides

#1024
US20230346886A1
Human necessities

NON-LEAKING OR MINIMALLY-LEAKING CHOROIDAL OR RETINAL REVASCULARIZATION

#1025 ✅ Patent 11,844,765 granted on 2023-12-19
US20230346887A1
Human necessities

Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

#1026
US20230346888A1
Human necessities

METHOD AND COMPOSITION OF TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION

#1027
US20230346889A9
Human necessities

TREATMENT OF ACUTE HEART FAILURE

#1028 ✅ Patent 12,220,444 granted on 2025-02-11
US20230346890A1
Human necessities

Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)

#1029 ✅ Patent 11,957,736 granted on 2024-04-16
US20230346891A1
Human necessities

Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

#1030
US20230346892A1
Human necessities

TREATMENT OF LONG BONE FRACTURES WITH ABALOPARATIDE

#1031
US20230346893A1
Human necessities

Methods and Compositions for Preventing or Minimizing Epithelial-Mesenchymal Transition

#1032
US20230346894A1
Human necessities

FORMULATION WITH CANNABINOIDS

#1033
US20230346896A1
Human necessities

METHOD FOR PREPARING POLYETHYLENE GLYCOL-MODIFIED URATE OXIDASE

#1034
US20230346897A1
Human necessities

METHOD AND DRUG FOR PROMOTING DEGRADATION OF MISFOLDED PROTEIN AND AGGREGATE THEREOF

#1035
US20230346898A1
Human necessities

USE OF THERMOLYSIN TO REDUCE OR ELIMINATE BACTERIAL BIOFILMS FROM SURFACES

#1036
US20230346899A1
Human necessities

PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + NIRMATRELVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDING COVID-19

#1037 ✅ Patent 12,029,782 granted on 2024-07-09
US20230346900A1
Human necessities

MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof

#1038
US20230346901A1
Human necessities

METHODS AND VACCINE COMPOSITIONS TO TREAT CANCERS

#1039
US20230346902A1
Human necessities

Shigella-Tetravalent (Shigella4V) Bioconjugate

#1040
US20230346903A1
Human necessities

GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF

#1041
US20230346904A1
Human necessities

BACTERIAL AND VIRAL VACCINE STRATEGY

#1042
US20230346905A1
Human necessities

PENTAVALENT VACCINE AGAINST NEISSERIA MENINGITIDIS COMPRISING A SYNTHETIC MEN A ANTIGEN

#1043
US20230346906A1
Human necessities

CANCER TREATMENT STRATEGIES USING ARENAVIRUS VECTORS

#1044
US20230346907A1
Human necessities

SEXUALLY TRANSMITTED DISEASE VACCINES

#1045 ✅ Patent 12,178,867 granted on 2024-12-31
US20230346908A1
Human necessities

MHC class i associated peptides for prevention and treatment of multiple flavi virus

#1046
US20230346909A1
Human necessities

NOVEL SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS

#1047 ✅ Patent 12,102,676 granted on 2024-10-01
US20230346910A1
Human necessities

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

#1048
US20230346911A1
Human necessities

BROADLY PROTECTIVE INFLUENZA B VIRUS VACCINES

#1049
US20230346912A1
Human necessities

RESTRICTIVE EPITOPE PEPTIDE OF MAJOR HISTOCOMPATIBILITY COMPLEX B2 OF H9N2 SUBTYPE AVIAN INFLUENZA VIRUS AND APPLICATION THEREOF

#1050
US20230346913A1
Human necessities

PRODUCTION OF FLU VACCINE IN MYCELIOPHTHORA THERMOPHILA

#1051
US20230346914A1
Human necessities

SARS-COV-2 MRNA DOMAIN VACCINES

#1052
US20230346915A1
Human necessities

Production Of Vaccines Comprising Inactivated SARS-COV-2 Viral Particles

#1053
US20230346916A1
Human necessities

IMMUNOGENIC COMPOSITIONS AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2

#1054
US20230346917A1
Human necessities

PARTICLES, DNA & RNA

#1055
US20230346919A1
Human necessities

SARS COV-2 VACCINES AND HIGH THROUGHPUT SCREENING ASSAYS BASED ON VESICULAR STOMATITIS VIRUS VECTORS

#1056
US20230346920A1
Human necessities

VACCINES AGAINST VIRAL PATHOGENS

#1057
US20230346921A1
Human necessities

CIRCULAR RNA VACCINES AND METHODS OF USE THEREOF

#1058
US20230346924A1
Human necessities

MRNA VACCINE COMPRISING ADJUVANT CAPABLE OF KINETIC CONTROL

#1059 ✅ Patent 11,957,750 granted on 2024-04-16
US20230346925A1
Human necessities

Triple vaccine protects against bacterial and fungal pathogens via trained immunity

#1060
US20230346926A1
Human necessities

METHODS OF TREATING ANKYLOSING SPONDYLITIS USING IL-17 ANTAGONISTS

#1061
US20230346927A1
Human necessities

COMBINATION of ATR KINASE INHIBITORS and PD-1/PD-L1 INHIBITORS

#1062
US20230346928A1
Human necessities

MRNA COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#1063
US20230346929A1
Human necessities

Stabilized Formulations Containing Anti-IL-33 Antibodies

#1064
US20230346931A1
Human necessities

ALTERNATIVE SURFACTANTS AS STABILIZERS FOR THERAPEUTIC PROTEIN FORMULATIONS

#1065
US20230346932A1
Human necessities

ETAR ANTIBODY, AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

#1066
US20230346933A1
Human necessities

ENGINEERED T CELLS, AND PREPARATION AND USE THEREOF

#1067
US20230346934A1
Human necessities

CHIMERIC SWITCH RECEPTORS FOR THE CONVERSION OF IMMUNESUPPRESSIVE SIGNALS TO COSTIMULATORY SIGNALS

#1068
US20230346935A1
Human necessities

TUMOR COMPLEX ANTIGEN, MULTIVALENT DENDRITIC CELL (DC) VACCINE, AND USE THEREOF

#1069
US20230346936A1
Human necessities

EX VIVO EXPANSION OF REGULATORY T CELLS FOR SUPPRESSION OF GRAFT VERSUS HOST DISEASE

#1070
US20230346937A1
Human necessities

OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTOR

#1071
US20230346938A1
Human necessities

CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND USE THEREOF

#1072
US20230346939A1
Human necessities

PROGRAMMING OF REGULATORY T CELLS BY EXTRACELLULAR VESICLES

#1073
US20230346940A1
Human necessities

Method And System For Identifying And Validating Shared Candidate Antigens And Shared Antigen-Specific T Lymphocyte Pairs

#1074
US20230346941A1
Human necessities

COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS

#1075
US20230346942A1
Human necessities

MACROMOLECULAR PRODRUGS FOR LIGHT-EMITTING DIODES AND USES THEREOF

#1076
US20230346943A1
Human necessities

SPACER-MEDIATED CONTROL OF UNCAGING PHOTOCAGED MOLECULES

#1077
US20230346944A1
Human necessities

VIRUS INACTIVATION METHOD, METHOD FOR MANUFACTURING PROTEIN DRUG, AND SYSTEM FOR PURIFYING SOLUTION

#1078
US20230346946A1
Human necessities

Nanostructured Gels Capable of Controlled Release of Encapsulated Agents

#1079 ✅ Patent 12,171,834 granted on 2024-12-24
US20230346947A1
Human necessities

Compositions and methods for inhibiting the activity of LAR family phosphatases

#1080
US20230346948A1
Human necessities

Lipid conjugated peptide inhibitors of PICK1

#1081
US20230346949A1
Human necessities

A METHOD OF FORMING A CONJUGATE OF A SULFONAMIDE AND A POLYPEPTIDE

#1082
US20230346950A1
Human necessities

MOLYBDENUM-BASED FEED SUPPLEMENT FOR BEES

#1083 ✅ Patent 12,128,105 granted on 2024-10-29
US20230346951A1
Human necessities

Molecular degraders of extracellular proteins

#1084
US20230346952A1
Human necessities

CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS

#1085 ✅ Patent 12,042,543 granted on 2024-07-23
US20230346953A1
Human necessities

Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhancer zeste homolog 2 (EZH2) and proteolysis-targeting chimeric derivatives thereof (PROTACs) that induce degradation of EZH2

#1086
US20230346954A1
Human necessities

N-1 BRANCHED IMIDAZOQUINOLINES, CONJUGATES THEREOF, AND METHODS

#1087
US20230346955A1
Human necessities

COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND USES THEREOF

#1088
US20230346956A1
Human necessities

COMPLEX OF 7-DEACETYLFORSKOLIN AND PVP

#1089
US20230346957A1
Human necessities

FGF-21 CONJUGATE FORMULATIONS

#1090
US20230346959A1
Human necessities

URATE OXIDASE PREPARATION AND USE THEREOF

#1091
US20230346960A1
Human necessities

PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR

#1092
US20230346961A1
Human necessities

GLP-1 AND GIP RECEPTOR CO-AGONISTS

#1093
US20230346963A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING DEMENTIA, CONTAINING PEPTIDE NUCLEIC ACID COMPLEX AS ACTIVE INGREDIENT

#1094
US20230346965A1
Human necessities

ENEDIYNE CONJUGATES

#1095
US20230346966A1
Human necessities

MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY

#1096 ✅ Patent 11,986,537 granted on 2024-05-21
US20230346967A1
Human necessities

Muscle targeting complexes and uses thereof for treating dystrophinopathies

#1097
US20230346968A1
Human necessities

ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS

#1098
US20230346969A1
Human necessities

INTERMEDIATE FOR PREPARING ANTIBODY-DRUG CONJUGATE (ADC), PREPARATION METHOD THEREFOR, AND USE THEREOF

#1099
US20230346970A1
Human necessities

CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND PSILOCYBIN

#1100
US20230346971A1
Human necessities

METHOD FOR TREATING TUMOURS BY CAPTURING COPPER AND/OR IRON

#1101 ✅ Patent 12,161,726 granted on 2024-12-10
US20230346972A1
Human necessities

Biomimetic vesicles and uses thereof

#1102
US20230346973A1
Human necessities

MICROORGANISM TARGETED NANOFORMULATIONS COMPRISING ANTIMICROBIAL COMPONENT(S)

#1103
US20230346975A1
Human necessities

DNA NANOSTRUCTURES FOR BOOSTING IMMUNITY AGAINST CANCER

#1104
US20230346976A1
Human necessities

MUSCLE-SPECIFIC HYBRID PROMOTER

#1105
US20230346977A1
Human necessities

TREATMENT OF NEUROMUSCULAR DISEASES VIA GENE THERAPY THAT EXPRESSES KLOTHO PROTEIN

#1106
US20230346978A1
Human necessities

DCAS13-MEDIATED THERAPEUTIC RNA BASE EDITING FOR IN VIVO GENE THERAPY

#1107
US20230346979A1
Human necessities

GENE THERAPIES FOR NEURODEGENERATIVE DISORDERS

#1108 ✅ Patent 12,083,189 granted on 2024-09-10
US20230346980A1
Human necessities

Tail-conjugated RNAs

#1109
US20230346981A1
Human necessities

ADENO-ASSOCIATED VIRAL VECTOR VARIANTS

#1110
US20230346982A1
Human necessities

FLUORESCENT CONTRAST AGENT WITH TARGETING FUNCTION, AND PREPARATION METHOD AND USE THEREOF

#1111
US20230346983A1
Human necessities

APPARATUS AND METHOD FOR DETECTING AND TREATING CANCEROUS TISSUE USING RAMAN SPECTROSCOPY AND HYPERTHERMIA

#1112
US20230346984A1
Human necessities

CHEMILUMINESCENT PROBES

#1113
US20230346985A1
Human necessities

ADENO-ASSOCIATED VIRUS VECTORS

#1114
US20230346986A1
Human necessities

METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER

#1115
US20230346987A1
Human necessities

STRUCTURAL DESIGN OF A CRANIAL NERVE DEGENERATION CONTRAST AGENT PRECURSORS

#1116
US20230346988A1
Human necessities

SYSTEMS FOR IN VIVO MONITORING OF IMMUNE CELLS IN PATIENTS UNDERGOING CELLULAR IMMUNOTHERAPY

#1117
US20230346989A1
Human necessities

FLUOROCARBON NANOEMULSIONS AND USES THEREOF IN IMAGING

#1118
US20230346990A1
Human necessities

HIGH MOLECULAR WEIGHT HEPARIN COMPOSITIONS AND METHODS FOR DIAGNOSING, TREATING AND MONITORING EOSINOPHIL MEDIATED INFLAMMATORY DISEASES

#1119 ✅ Patent 11,865,196 granted on 2024-01-09
US20230346992A1
Human necessities

Engineered radioactive polymeric microsphere, and preparation and application thereof

#1120
US20230346993A1
Human necessities

ULTRAVIOLET STERILIZATION FOR MINIMALLY INVASIVE SYSTEMS

#1121
US20230346994A1
Human necessities

ELECTROCEUTICAL FABRIC FOR ERADICATING CORONAVIRUS

#1122
US20230346995A1
Human necessities

USE OF ELECTRIC CURRENT OR FIELD TO MANAGE RISK OF INFECTION BY ANTIMICROBIAL-RESISTANT MICROORGANISMS

#1123
US20230346996A1
Human necessities

SANITIZATION EDGE COMPUTE DEVICE

#1124
US20230346997A1
Human necessities

COLD PLASMA VAPOR SANITIZER

#1125
US20230346998A1
Human necessities

MISTY PLASMA DIELECTRIC BARRIER DISCHARGE PLASMA SYSTEM FOR DISINFECTION

#1126
US20230346999A1
Human necessities

DECONTAMINATION METHOD

#1127
US20230347000A1
Human necessities

Portable Systems and Methods for Treating Materials with an Antimicrobial Agent

#1128
US20230347001A1
Human necessities

SANITIZATION SYSTEMS WITH SAFETY FEATURES

#1129
US20230347002A1
Human necessities

DECONTAMINATION DEVICE

#1130
US20230347003A1
Human necessities

ATOMIZER APPARATUS AND METHODS OF USE THEREOF

#1131
US20230347004A1
Human necessities

Liner for Home Decor Wax Warmers

#1132
US20230347005A1
Human necessities

Adjustable electronic fragrance emitter and method

#1133
US20230347006A1
Human necessities

STERILIZATION ATOMIZATION DEVICE

#1134
US20230347007A1
Human necessities

APPARATUS FOR DECONTAMINATING AMBIENT AIR IN AN INDOOR ENVIRONMENT

#1135 ✅ Patent 11,890,398 granted on 2024-02-06
US20230347008A1
Human necessities

Air cleaning device

#1136
US20230347009A1
Human necessities

DISPOSABLE CONTACT LENS CLEANSING DEVICE

#1137 ✅ Patent 11,964,073 granted on 2024-04-23
US20230347011A1
Human necessities

Cured adhesive compositions and method of making

#1138
US20230347012A1
Human necessities

BIORESORBABLE EMBOLIZATION PARTICLES

#1139
US20230347013A1
Human necessities

Bendable Titanium-Alloy Implants, And Related Systems And Methods

#1140
US20230347014A1
Human necessities

RESORBABLE COMPLEX SHAPE MEMORY POLY(PROPYLENE FUMARATE) STAR SCAFFOLDS FOR 4D PRINTING APPLICATIONS

#1141
US20230347015A1
Human necessities

LYOPHILIZED PERFORATED PLACENTAL MEMBRANE TISSUE GRAFTS

#1142
US20230347016A1
Human necessities

VALVE MATERIAL WITH LONG-ACTING ANTITHROMBOSIS PROPERTY AND PREPARATION METHOD THEREFOR

#1143
US20230347017A1
Human necessities

SHEET-SHAPED CELL CULTURE FOR COVERING CUT SURFACE OF PANCREAS

#1144
US20230347018A1
Human necessities

METHODS AND DEVICES FOR CELLULAR TRANSPLANTATION

#1145
US20230347019A1
Human necessities

IMPROVED BONE GRAFT SUBSTITUTE FORMULATION

#1146 ✅ Patent 11,918,768 granted on 2024-03-05
US20230347020A1
Human necessities

Medical devices for fluid delivery and methods of use and manufacture

#1147
US20230347021A1
Human necessities

MANIPULATING AND DETECTING BIOLOGICAL SAMPLES

#1148 ✅ Patent 12,102,737 granted on 2024-10-01
US20230347022A1
Human necessities

Drug coated balloon catheters for nonvascular strictures

#1149 ✅ Patent 12,109,334 granted on 2024-10-08
US20230347023A1
Human necessities

Three dimensional electrospun biomedical patch for facilitating tissue repair

#1150
US20230347024A1
Human necessities

BIOLOGICAL COVER

#1151
US20230347025A1
Human necessities

IMPLANT HAVING CONTROLLED GENERATION RATE OF REACTIVE OXYGEN SPECIES AND METHOD OF CONTROLLING GENERATION OF REACTIVE OXYGEN SPECIES USING THE SAME

#1152 ✅ Patent 11,986,580 granted on 2024-05-21
US20230347026A1
Human necessities

Wearable breast pump

#1153 ✅ Patent 12,011,525 granted on 2024-06-18
US20230347027A1
Human necessities

Medical fluid delivery system including remote machine updating and control

#1154
US20230347028A1
Human necessities

DIALYSIS BIOMARKER MONITORING

#1155
US20230347029A1
Human necessities

DIALYSIS BIOMARKER MONITORING

#1156
US20230347030A1
Human necessities

MEDICAL APPLIANCE FOR EXTRACORPOREAL BLOOD TREATMENT

#1157
US20230347031A1
Human necessities

DIALYSATE REGENERATOR AND SYSTEM COMPRISING THE SAME

#1158
US20230347032A1
Human necessities

MEMBRANE OXYGENATOR

#1159 ✅ Patent 12,029,841 granted on 2024-07-09
US20230347033A1
Human necessities

System and method for cardiopulmonary bypass using hypobaric oxygenation

#1160
US20230347034A1
Human necessities

STATUS ASSESSMENT OF AN INDIVIDUAL UNDERGOING PERITONEAL DIALYSIS

#1161 ✅ Patent 11,951,241 granted on 2024-04-09
US20230347035A1
Human necessities

Peritoneal dialysis system and methods

#1162
US20230347036A1
Human necessities

Device For Determining The Level Of Haemoglobin Or Haematocrit Of A Circulating Liquid

#1163
US20230347037A1
Human necessities

MATRICES FOR SELECTIVE BINDING OF AT LEAST ONE COMPONENT FROM A BODY FLUID

#1164
US20230347038A1
Human necessities

SURGICAL SITE AIR EVACUATION DEVICE AND METHODS OF USE

#1165
US20230347039A1
Human necessities

WOUND-CLEANSING PAD APPARATUS AND METHODS OF USE

#1166
US20230347040A1
Human necessities

SYSTEMS AND METHODS FOR CONTROLLING FLUID INSTILLATION THERAPY USING PH FEEDBACK

#1167
US20230347041A1
Human necessities

PRESSURIZED WATER FLUID DISTRIBUTION

#1168
US20230347042A1
Human necessities

CONTRAST MEDIUM INJECTION DEVICE AND INJECTION LINE KIT

#1169
US20230347043A1
Human necessities

SYSTEM AND METHOD FOR IMPROVED FLUID DELIVERY IN MULTI-FLUID INJECTOR SYSTEMS

#1170
US20230347045A1
Human necessities

Smart Self-Activating Wearable Device for Automatically Injecting Medicines

#1171
US20230347046A1
Human necessities

SYSTEMS AND METHODS FOR DETECTING DISRUPTIONS IN FLUID DELIVERY DEVICES

#1172
US20230347047A1
Human necessities

CONTROL SYSTEM FOR INFUSION PUMP

#1173
US20230347048A1
Human necessities

TREATMENT DEVICE OF CEREBROVASCULAR DISORDER

#1174
US20230347049A1
Human necessities

RADIO FREQUENCY OPERATION DATA CONTROL METHOD, APPARATUS, AND SYRINGE PUMP

#1175
US20230347050A1
Human necessities

Synthetic thyroid methods and apparatus

#1176 ✅ Patent 11,938,302 granted on 2024-03-26
US20230347051A1
Human necessities

Method for controlling artificial pancreas including insulin patch and device therefor

#1177 ✅ Patent 12,064,600 granted on 2024-08-20
US20230347052A1
Human necessities

Acoustic method for precisely controlling and metering the manual injection dosage

#1178
US20230347053A1
Human necessities

ADAPTATION OF A MEDICAMENT DELIVERY DEVICE TO CHANGING ENVIRONMENTAL CONDITIONS

#1179 ✅ Patent 11,957,879 granted on 2024-04-16
US20230347054A1
Human necessities

Autoinjector

#1180
US20230347055A1
Human necessities

MEDICAMENT DELIVERY DEVICE

#1181
US20230347056A1
Human necessities

Injection Device with a Vibration Generator

#1182
US20230347057A1
Human necessities

VACUUM GENERATION DEVICES AND METHODS

#1183
US20230347058A1
Human necessities

APPARATUS FOR OPERATING SYRINGE

#1184
US20230347059A1
Human necessities

MIXING VIAL

#1185
US20230347060A1
Human necessities

NEEDLE-FREE INJECTOR BASED ON UNDERWATER DISCHARGE USING SHOCK WAVE

#1186 ✅ Patent 12,343,507 granted on 2025-07-01
US20230347061A1
Human necessities

GLASS SYRINGE BARRELS WITH INCREASED CONE BREAKING FORCES

#1187
US20230347062A1
Human necessities

DEVICE FOR ADMINISTERING A LIQUID TO A HUMAN BY MEANS OF INJECTION, COMBINATION OF SUCH A DEVICE AND AN INJECTOR COMPRISING AN INDIVIDUAL DOSE OF A LIQUID AND AN INJECTION NEEDLE, AND METHOD FOR MANIPULATING AN INJECTOR

#1188
US20230347063A1
Human necessities

CONTAINER WITH PLUNGER AND LOCKING ARRANGEMENT

#1189
US20230347064A1
Human necessities

MULTIPLE USE DISPOSABLE INJECTION PEN

#1190
US20230347065A1
Human necessities

ELECTRONIC SYSTEM FOR A DRUG DELIVERY DEVICE, DRUG DELIVERY DEVICE, AND ASSOCIATED METHOD

#1191
US20230347066A1
Human necessities

INJECTION MONITORING MODULE

#1192
US20230347067A1
Human necessities

Auto-injector and its actuation assembly

#1193
US20230347068A1
Human necessities

DOSE DELIVERY MECHANISM

#1194
US20230347069A1
Human necessities

HOLDER FOR SYRINGES AND OTHER MEDICAL INSTRUMENTS

#1195
US20230347070A1
Human necessities

MEDICAMENT DELIVERY DEVICE

#1196
US20230347071A1
Human necessities

Needle Shield Removal Assembly, Method for Assembling Thereof and Drug Delivery Device

#1197
US20230347072A1
Human necessities

Needle Protection Assembly

#1198
US20230347073A1
Human necessities

INJECTION SYRINGE

#1199
US20230347074A1
Human necessities

MULTI-STAGE INJECTION DEVICE

#1200
US20230347075A1
Human necessities

FLOW RESTRICTOR FOR DRUG DELIVERY DEVICE